Relipac 30Mg/5Ml Inj belongs to the group of anti-cancer medicines called anti-microtubule agents used to treat various types of cancers, including ovarian and breast cancer (in advanced/spreading state or after surgery) and advanced-stage non-small cell lung cancer. It may also be used when other treatments have failed or in combination with other treatments. Relipac 30Mg/5Ml Inj may also be indicated in patients with Kaposi’s sarcoma (cancer that develops from the cells that line lymph or blood vessels) associated with AIDS (Acquired Immuno-Deficiency Syndrome), where other treatments have not been effective. Relipac 30Mg/5Ml Inj contains ‘Paclitaxel’, which works by preventing the growth of certain cancer cells.

FAQs

What is the use of Relipac 30Mg/5Ml Inj?

Relipac 30Mg/5Ml Inj is used to treat Ovarian cancer, breast cancer, non-small cell lung cancer.

How does Relipac 30Mg/5Ml Inj work?

Relipac 30Mg/5Ml Inj works by stopping cell division and preventing the growth of certain cancer cells.

Does Relipac 30Mg/5Ml Inj affect fertility?

Relipac 30Mg/5Ml Inj might cause sterility which could be permanent. Please talk to your doctor if you have any concerns.

Does Relipac 30Mg/5Ml Inj cause hair loss?

The most common side effect of Relipac 30Mg/5Ml Inj is hair loss. The hair may grow back after the treatment with Relipac 30Mg/5Ml Inj is finished. However, consult your doctor if you have any concerns.

Is Relipac 30Mg/5Ml Inj cytotoxic?

Yes, Relipac 30Mg/5Ml Inj is cytotoxic. It works by interfering with the growth of cancer cells, preventing them from dividing and causing them to die. However, its cytotoxic nature also means it can affect normal, healthy cells, potentially leading to side effects.

Is Relipac 30Mg/5Ml Inj a vesicant?

Yes, Relipac 30Mg/5Ml Inj is considered a vesicant. A vesicant is a chemical substance that, if it leaks out of the vein (extravasation), can cause blistering of the skin and surrounding tissues. If Relipac 30Mg/5Ml Inj accidentally leaks during intravenous (IV) infusion, it may lead to inflammation, blistering, or even tissue necrosis. Your healthcare provider will take precautions to ensure the drug is infused properly and monitor the infusion site for any signs of leakage. If extravasation occurs, the infusion should be stopped immediately, and steps should be taken to minimize the damage.

Is Relipac 30Mg/5Ml Inj cardiotoxic?

Relipac 30Mg/5Ml Inj is an effective cancer treatment with a low risk of cardiac side effects. Your healthcare team will closely monitor your heart function to ensure your safety. They'll watch for any changes in heart rhythms or blood pressure, and work with you to manage any potential issues. With careful monitoring, you can receive this life-saving treatment with confidence.

What is Relipac 30Mg/5Ml Inj derived from?

Relipac 30Mg/5Ml Inj is a natural product derived from the bark of the Pacific yew tree (Taxus baccata). It is a chemotherapy medication used to treat various cancers, including breast, ovarian, and lung cancer.

What are the side effects of Relipac 30Mg/5Ml Inj?

The common side effects of Relipac 30Mg/5Ml Inj include nausea, vomiting, mild diarrhoea, and joint or muscle pain. Not everyone will experience all of these side effects, and they typically resolve once the treatment is stopped. However, if the side effects persist or worsen, please consult your doctor.